Matches in SemOpenAlex for { <https://semopenalex.org/work/W2327733925> ?p ?o ?g. }
Showing items 1 to 84 of
84
with 100 items per page.
- W2327733925 abstract "The biological fate of suxibuzone (SB), a new non-steroidal anti-inflammatory agent, was studied in healthy male volunteers with single oral doses and compared with that of phenylbutazone (PB) by a cross-over test, with the following results:1) PB, oxyphenbutazone (Oxy-PB), and γ-hydroxy-phenylbutazone (γ-Hydroxy-PB) were identified in plasma after oral administration of SB. Moreover these metabolites, their glucuronides, SB-glucuronide, 4-hydroxymethyl-phenylbutazone (4-HM-PB)-glucuronide, and p, γ-dihydroxy-phenylbutazone (p, γ-DH-PB) were found in urine.2) Peak plasma concentration of the metabolites was obtained 4 hrs after a single oral dose of 426 mg of SB when the concentration of PB, the main metaboliteof SB, was 36μg/ml, much the same as the corresponding level in the volunteers receiving PB. On the other hand, there was no difference between volunteers receiving SB and PB interms of the concentration of Oxy-PB. But the concentration of γ-Hydroxy-PB was higher after oral SB than after oral PB.3) Urinary excretion of the metabolites was about 8% of the administered dose up to 16 8hrs after oral doses of SB or PB, but in the period shortly after oral doses of SB, Oxy-PB-glucuronide and γ-Hydroxy-PB were excreted to ag reater extent than after oral doses of PB.4) From these results in the plasma and urine after oral doses of SB, it was found that SB may be characterized as a prodrug of PB.5) During the experiment, no side effects or abnormalities were observed in the medical examination and laboratory test except for a slight decrease in the uric acid level in plasma." @default.
- W2327733925 created "2016-06-24" @default.
- W2327733925 creator A5037824120 @default.
- W2327733925 creator A5047941938 @default.
- W2327733925 creator A5048477345 @default.
- W2327733925 creator A5067311280 @default.
- W2327733925 creator A5082023853 @default.
- W2327733925 creator A5087446395 @default.
- W2327733925 creator A5087771741 @default.
- W2327733925 date "1979-01-01" @default.
- W2327733925 modified "2023-09-25" @default.
- W2327733925 title "The Biological Fate of Suxibuzone V" @default.
- W2327733925 cites W136832764 @default.
- W2327733925 cites W2045402447 @default.
- W2327733925 cites W2067411920 @default.
- W2327733925 cites W2078205693 @default.
- W2327733925 cites W2247938431 @default.
- W2327733925 doi "https://doi.org/10.3999/jscpt.10.525" @default.
- W2327733925 hasPublicationYear "1979" @default.
- W2327733925 type Work @default.
- W2327733925 sameAs 2327733925 @default.
- W2327733925 citedByCount "1" @default.
- W2327733925 crossrefType "journal-article" @default.
- W2327733925 hasAuthorship W2327733925A5037824120 @default.
- W2327733925 hasAuthorship W2327733925A5047941938 @default.
- W2327733925 hasAuthorship W2327733925A5048477345 @default.
- W2327733925 hasAuthorship W2327733925A5067311280 @default.
- W2327733925 hasAuthorship W2327733925A5082023853 @default.
- W2327733925 hasAuthorship W2327733925A5087446395 @default.
- W2327733925 hasAuthorship W2327733925A5087771741 @default.
- W2327733925 hasBestOaLocation W23277339251 @default.
- W2327733925 hasConcept C185592680 @default.
- W2327733925 hasConcept C2775844104 @default.
- W2327733925 hasConcept C2777056448 @default.
- W2327733925 hasConcept C2777477808 @default.
- W2327733925 hasConcept C2777837344 @default.
- W2327733925 hasConcept C2779186261 @default.
- W2327733925 hasConcept C2780026642 @default.
- W2327733925 hasConcept C3019361228 @default.
- W2327733925 hasConcept C3020079912 @default.
- W2327733925 hasConcept C43617362 @default.
- W2327733925 hasConcept C55493867 @default.
- W2327733925 hasConcept C71924100 @default.
- W2327733925 hasConcept C98274493 @default.
- W2327733925 hasConceptScore W2327733925C185592680 @default.
- W2327733925 hasConceptScore W2327733925C2775844104 @default.
- W2327733925 hasConceptScore W2327733925C2777056448 @default.
- W2327733925 hasConceptScore W2327733925C2777477808 @default.
- W2327733925 hasConceptScore W2327733925C2777837344 @default.
- W2327733925 hasConceptScore W2327733925C2779186261 @default.
- W2327733925 hasConceptScore W2327733925C2780026642 @default.
- W2327733925 hasConceptScore W2327733925C3019361228 @default.
- W2327733925 hasConceptScore W2327733925C3020079912 @default.
- W2327733925 hasConceptScore W2327733925C43617362 @default.
- W2327733925 hasConceptScore W2327733925C55493867 @default.
- W2327733925 hasConceptScore W2327733925C71924100 @default.
- W2327733925 hasConceptScore W2327733925C98274493 @default.
- W2327733925 hasLocation W23277339251 @default.
- W2327733925 hasOpenAccess W2327733925 @default.
- W2327733925 hasPrimaryLocation W23277339251 @default.
- W2327733925 hasRelatedWork W137756846 @default.
- W2327733925 hasRelatedWork W1589520545 @default.
- W2327733925 hasRelatedWork W1966851663 @default.
- W2327733925 hasRelatedWork W1976030268 @default.
- W2327733925 hasRelatedWork W1977715056 @default.
- W2327733925 hasRelatedWork W1982315456 @default.
- W2327733925 hasRelatedWork W2019338974 @default.
- W2327733925 hasRelatedWork W2025220349 @default.
- W2327733925 hasRelatedWork W2031917896 @default.
- W2327733925 hasRelatedWork W2093386822 @default.
- W2327733925 hasRelatedWork W2332839231 @default.
- W2327733925 hasRelatedWork W2337434218 @default.
- W2327733925 hasRelatedWork W2399359238 @default.
- W2327733925 hasRelatedWork W2410248005 @default.
- W2327733925 hasRelatedWork W2414261505 @default.
- W2327733925 hasRelatedWork W2417300792 @default.
- W2327733925 hasRelatedWork W2430176666 @default.
- W2327733925 hasRelatedWork W2439431945 @default.
- W2327733925 hasRelatedWork W2474292417 @default.
- W2327733925 hasRelatedWork W3141319650 @default.
- W2327733925 isParatext "false" @default.
- W2327733925 isRetracted "false" @default.
- W2327733925 magId "2327733925" @default.
- W2327733925 workType "article" @default.